Camurus Announces Remarkable Results for Monthly Semaglutide CAM2056 in Phase 1b Study Camurus reports impressive topline findings from Phase 1b study on CAM2056, a monthly semaglutide formulation, showing significant weight loss and A1c reductions.

Camurus Announces Remarkable Results for Monthly Semaglutide CAM2056 in Phase 1b Study #Sweden #Lund #Semaglutide #Camurus #CAM2056

Camurus Reports Remarkable Results for New Semaglutide Depot CAM2056 in Weight and Glycemic Control Camurus has unveiled promising findings from their Phase 1b study of CAM2056, a monthly semaglutide depot, revealing significant weight loss and A1c improvements.

Camurus Reports Remarkable Results for New Semaglutide Depot CAM2056 in Weight and Glycemic Control #Sweden #Lund #Semaglutide #Camurus #CAM2056